GAL

The GAL/GMAP locus is bicistronic in function within this corpus, encoding both the Golgi-associated coiled-coil protein GMAP-210 (TRIP11) and the galanin/GMAP neuropeptide precursor (PMID:10189370, PMID:9512271). GMAP-210 is a microtubule-binding protein that tethers the cis-Golgi network to centrosome-nucleated microtubules: its COOH-terminus binds microtubule minus ends while its NH2-terminus anchors to Golgi membranes, and the C-terminus recruits gamma-tubulin complexes to Golgi membranes independently of microtubule polymerization (PMID:10189370, PMID:15294158). Through this anchoring it maintains Golgi ribbon integrity—depletion fragments the Golgi while overexpression enlarges and disassembles it—and supports bidirectional ER-Golgi vesicular trafficking, acting partially redundantly with GM130 for anterograde cargo delivery to the cis-Golgi (PMID:12383348, PMID:15294158, PMID:25717001). A LIR motif in GMAP mediates direct interaction with Atg8/LC3 to drive selective autophagy of the Golgi (Golgiphagy), regulating Golgi size and morphology (PMID:35649355). Loss-of-function mutations in TRIP11 cause achondrogenesis type 1A, with chondrocytes showing disturbed Golgi architecture, altered glycosylation, and selective intracellular accumulation of perlecan (PMID:20089971). Separately, the galanin/GMAP neuropeptide is concentrated in noradrenergic locus coeruleus terminals projecting to hippocampus and cortex, is upregulated in sensory neurons after peripheral axotomy via LIF signaling, and modulates spinal nociceptive transmission (PMID:9512271, PMID:8951409, PMID:7603589); its receptor Gal1R switches G-protein coupling from Gi to Gs upon forming heterotetramers with µ-opioid receptors (PMID:35750299).

1. 1999 High

   Established the core biochemical activity of GMAP-210 by showing it physically bridges the cis-Golgi to microtubules, defining the molecular basis for Golgi positioning.

   Evidence In vitro microtubule-binding assay with deletion analysis and GFP-fusion overexpression

   PMID:10189370

   Open questions at the time

   • Overexpression phenotype may not reflect endogenous stoichiometry
   • Did not address how membrane and microtubule binding are coordinated in vivo
2. 2002 Medium

   Linked GMAP-210 dosage to vesicular transport by showing its overexpression blocks both anterograde and retrograde ER-Golgi traffic, implicating it in trafficking beyond static tethering.

   Evidence Overexpression with multiple cargo transport assays and ultrastructural analysis

   PMID:12383348

   Open questions at the time

   • Overexpression approach risks dominant-negative artifact
   • No rescue or loss-of-function complement
3. 2004 High

   Defined GMAP-210 as a microtubule-anchoring factor that recruits gamma-tubulin to the Golgi, explaining how it nucleates/anchors microtubules at the Golgi surface; RNAi depletion confirmed it is required for Golgi integrity.

   Evidence RNAi knockdown plus gain-of-function mitochondrial retargeting with gamma-tubulin immunofluorescence

   PMID:15294158

   Open questions at the time

   • Direct gamma-tubulin complex binding interface not mapped
   • Relationship between gamma-tubulin recruitment and trafficking function unresolved
4. 2010 High

   Connected GMAP-210 loss to human disease, showing TRIP11 mutations cause achondrogenesis type 1A through Golgi-dependent glycosylation defects and cargo-selective trafficking failure.

   Evidence Positional cloning, mouse knockout, human patient sequencing, glycosylation and cargo-specific immunostaining assays

   PMID:20089971

   Open questions at the time

   • Why perlecan but not collagen II/aggrecan is selectively retained is unexplained
   • Mechanism linking Golgi architecture loss to glycosylation defect not detailed
5. 2015 Medium

   Refined GMAP-210's trafficking role by demonstrating it functions at both ERGIC and Golgi and acts redundantly with GM130, clarifying the network of golgins supporting cargo delivery.

   Evidence siRNA knockdown with co-depletion epistasis and transport assays

   PMID:25717001

   Open questions at the time

   • Degree of functional overlap with other golgins not exhaustively tested
   • Single-lab transport assays
6. 2022 Medium

   Identified a new regulatory mechanism for Golgi homeostasis by showing GMAP uses a LIR motif to drive selective autophagy of the Golgi (Golgiphagy).

   Evidence Atg8a-LDS proteomics and GMAP LIR mutant fly generation with Golgi marker imaging

   PMID:35649355

   Open questions at the time

   • Demonstrated in Drosophila ortholog; mammalian conservation not shown in this corpus
   • Trigger and physiological context of Golgiphagy unknown
7. 1996 Medium

   Identified LIF as an upstream regulator of injury-induced galanin/GMAP expression, framing the neuropeptide arm as part of a regulated nerve-injury response.

   Evidence Sciatic nerve axotomy in LIF-knockout vs wild-type mice with immunofluorescence quantification

   PMID:8951409

   Open questions at the time

   • Downstream signaling from LIF to GAL/GMAP transcription not mapped
   • Single-lab knockout model
8. 1998 Medium

   Localized the galanin/GMAP neuropeptide to noradrenergic locus coeruleus terminals in hippocampus and cortex, establishing its anatomical neurotransmitter context.

   Evidence Immunofluorescence double-staining with 6-OHDA lesion and reserpine depletion

   PMID:9512271

   Open questions at the time

   • Functional consequence of co-release with noradrenaline not addressed
   • Receptor mediating effects in these regions not identified here
9. 1995 Medium

   Characterized the GMAP neuropeptide's modulation of spinal nociception and its plasticity after nerve injury, showing it antagonizes substance P-driven reflex facilitation and shifts specificity after axotomy.

   Evidence Intrathecal peptide administration, flexor reflex electrophysiology, axotomy and immunohistochemistry; plus RTX-induced mRNA/peptide upregulation by in situ hybridization

   PMID:7603589 PMID:8595209

   Open questions at the time

   • Receptor mediating GMAP's spinal effects not identified
   • RTX upregulation is correlative without mechanistic dissection
10. 2022 Medium

    Revealed that the galanin Gal1 receptor reverses its G-protein output by switching from Gi to Gs upon heterotetramerizing with µ-opioid receptors, providing a mechanism for galanin-opioid crosstalk.

    Evidence Peptide-interfering approach, TIRF microscopy, co-IP, BRET/FRET and cAMP assays

    PMID:35750299

    Open questions at the time

    • Physiological/in vivo relevance of the coupling switch not established
    • Single-lab biophysical characterization

• How the two distinct functional outputs of the GAL/GMAP locus—the Golgi-tethering GMAP-210 protein and the secreted galanin/GMAP neuropeptide—are co-regulated or whether they share any mechanistic interplay remains unresolved.
• No corpus finding links the trafficking and neuropeptide functions mechanistically
• Conservation of Golgiphagy in mammals untested
• In vivo significance of Gal1R-MOR coupling switch unknown